Global CRISPR Market Forecast 2017-2025 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Crispr Market Forecast 2017-2025" report to their offering.

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is fragments of prokaryotic DNA containing short redundancies of base sequences.

The Global CRISPR market by application generated revenue of $361 Million in 2016 and is anticipated to contribute $5966 Million by 2025, growing at a CAGR of 36.79% during the forecasted period of 2017-2025. The global CRISPR market is segmented on the basis of geographical analysis, product and end-user.

Increasing demand in drug discovery, late pregnancies leading to birth disorders, synthetic genes leading the way; aging genetic disorders and investment in path breaking research technology are the drivers for CRISPR Market. Drug discovery technology market plays a dominant role in boosting the CRISPR market. Genome editing has been revolutionized with the discovery of the CRISPR-CAS9 system from streptococcus pyogenes.

The possible misuse of CRISPR gene editing tool, slow growth and lack of healthcare budgets in developing countries are some of the restraints for CRISPR Market. CRISPR is linked with various applications such as Genome editing, genetic engineering etc. These applications are considered controversial due to the ethical concerns.

The global CRISPR Market covers the regions of North America, Europe and Asia Pacific. North America is the leading and has the biggest CRISPR Market; it is also anticipated that it will dominate the global cell therapy market. Europe CRISPR market is estimated to grow during the forecast period. Asia Pacific is a dominating region for CRISPR market with its applications like agriculture and animal breeding.

The major market players for CRISPR market are Editas Medicine, Crispr Therapeutics Ag, Horizon Discovery Plc., Sigma-Aldrich, Genscript, Transposagen Biopharmaceuticals, Thermo Fisher Scientific, Caribou Biosciences, Inc., and Precision Biosciences among others.

Market Determinants

Drivers

  • Increasing Demand In For Drug Discovery
  • Late Pregnancies Leading To Birth Disorders
  • Synthetic Genes Lead The Way
  • Aging Genetic Disorders
  • Investment In Path Breaking Research Technology
  • Changing Lifestyles

Restraints

  • Possible Misuse Of Crispr Gene Editing Tool
  • Slow Growth
  • Lack Of Healthcare Budgets In Developing Countries

Opportunities

  • Genome Surgery To Rewrite Genetic Disorders
  • Clinical Trials In Asia

Challenges

  • Protection Of Patent
  • Alternate Technologies
  • Lack Of Healthcare Budgets In Developing Countries

Key Topics Covered:

1. Research Scope

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Analytical Overview

6. Market Determinants

7. Market Segmentation

8. Geographical Analysis

9. Company Profiling

  • Editas Medicine
  • Crispr Therapeutics AG
  • Horizon Discovery Plc.
  • Sigma-Aldrich
  • Genscript
  • Sangamo Biosciences, Inc.
  • Lonza Group AG
  • Integrated Dna Technologies (Idt)
  • New England Biolabs inc.
  • Origene Technologies Inc.
  • Transposagen Biopharmaceuticals
  • Thermo Fisher Scientific
  • Caribou Biosciences, Inc.
  • Precisionbiosciences
  • Cellectis
  • Intellia Therapeutics, Inc

For more information about this report visit http://www.researchandmarkets.com/research/63hp4q/global_crispr

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Genomics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Genomics